Spondylitis, Ankylosing Clinical Trials

61 clinical trials for Spondylitis, Ankylosing across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Natural History and Development of Spondyloarthritis — RECRUITING
Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application-related Outcome Measurement (AbEM) Within the Routine Prescription of the DiGA Axia. — RECRUITING · NA
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases — RECRUITING
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism — COMPLETED
An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs) — TERMINATED · PHASE4
Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA — COMPLETED · NA
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases — ACTIVE_NOT_RECRUITING · PHASE4
Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease — NOT_YET_RECRUITING
Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis — WITHDRAWN
A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis — COMPLETED · PHASE4
The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients — COMPLETED · NA
Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response. — OTHER
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108) — COMPLETED · PHASE3
A Study of CC-99677 in Participants With Active Ankylosing Spondylitis — TERMINATED · PHASE2
The Relationship Between Inflammatory ARTritis and CArdiac DIseAse — ACTIVE_NOT_RECRUITING
Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis — COMPLETED · PHASE3
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study — COMPLETED
Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis — COMPLETED
Novel Quantitative MRI for Axial Spondyloarthritis — TERMINATED
Survey About Diet in Chronic Inflammatory Rheumatic Diseases — OTHER
Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers — COMPLETED · NA
Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis — COMPLETED
Analysis of DNA Methylation in Spondyloarthritis — COMPLETED · NA
Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA — COMPLETED · PHASE4
Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis — COMPLETED · NA
Effects of Tai Chi in Patients With Ankylosing Spondylitis Receiving Anti-tumor Necrosis Factor Alpha Therapy — COMPLETED · NA
Extension in AS: Sustainability of Benefits, Safety and Tolerability — COMPLETED · PHASE3
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis — COMPLETED · PHASE3
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) — COMPLETED · PHASE3
16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients — COMPLETED · PHASE3
An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement — TERMINATED
A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED) — COMPLETED · PHASE4
Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED) — COMPLETED · PHASE4
Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352) — COMPLETED · PHASE3
Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440) — TERMINATED · PHASE4
Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study — COMPLETED · PHASE4
A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554) — COMPLETED
Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain — COMPLETED
C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France — COMPLETED
A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis — OTHER · PHASE2
Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial — COMPLETED · NA
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) — COMPLETED
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes — COMPLETED · PHASE3
Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED) — COMPLETED
Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED) — COMPLETED
Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED) — COMPLETED · PHASE4
Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health Subjects — COMPLETED
Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) — WITHDRAWN · PHASE3
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants — COMPLETED
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis — COMPLETED · PHASE3

Refine this search